Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding OptiNose, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of OPTN: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders4449+5
Shares45.4M45.5M+94.5K (+0.2%)
Value$111.9M$166.4M+$54.5M (+48.7%)

New holders (8)

Institutions that held OptiNose, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to OPTN in Q2 2022
InstitutionSharesValue% of portfolio
EAM Investors, LLC265,823$973.0K0.24%
Opaleye Management Inc.90,970$333.0K0.15%
Qube Research & Technologies Ltd49,158$180.0K0.00%
Walleye Capital LLC36,226$133.0K0.00%
Susquehanna International Group, LLP10,984$40.0K0.00%
Daiwa Securities Group Inc.308$1.00K0.00%
Oxler Private Wealth LLC100$3660.00%
Simplex Trading, LLC163$00.00%

Sold out (3)

Institutions that held OptiNose, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of OPTN in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Group One Trading, L.P.12,200$30.0K
Arete Wealth Advisors, LLC12,000$30.0K
Jump Financial, LLC11,402$28.0K